
Pharmascience
North America, Quebec, Canada, Montréal
Description
Pharmascience is a manufacturer of generic drugs.
Investor Profile
Pharmascience has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Pharmaceutical, Biotechnology, Health Care.
Stage Focus
- Private Equity (20%)
- Series B (20%)
- Series Unknown (20%)
- Post Ipo Equity (20%)
- Series A (20%)
Country Focus
- United States (60%)
- Israel (20%)
- Canada (20%)
Industry Focus
- Pharmaceutical
- Biotechnology
- Health Care
- Clinical Trials
- Manufacturing
- Therapeutics
- Medical
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Pharmascience frequently co-invest with?
What are some of recent deals done by Pharmascience?
Find More Investors Like Pharmascience
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides







